Found: 14
Select item for more details and to access through your institution.
The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 559, doi. 10.3390/vaccines12050559
- By:
- Publication type:
- Article
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1792, doi. 10.3390/vaccines11121792
- By:
- Publication type:
- Article
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00772-1
- By:
- Publication type:
- Article
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37715-2
- By:
- Publication type:
- Article
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00301-y
- By:
- Publication type:
- Article
Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225063
- By:
- Publication type:
- Article
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0063-7
- By:
- Publication type:
- Article
Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02350
- By:
- Publication type:
- Article
Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0202820
- By:
- Publication type:
- Article
Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145243
- By:
- Publication type:
- Article
Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine.
- Published in:
- Virology Journal, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12985-015-0435-9
- By:
- Publication type:
- Article
A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 4, p. 1, doi. 10.1093/ofid/ofv166
- By:
- Publication type:
- Article
Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0135723
- By:
- Publication type:
- Article
Transient Humoral Protection against H5N1 Challenge after Seasonal Influenza Vaccination of Humans.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0103550
- By:
- Publication type:
- Article